|
|
Volumn 13, Issue 6, 2002, Pages 625-630
|
|
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer
a
a
a
a
a
a
a
a
a
|
|
Author keywords
Caelyx; Chemotherapy; Combination; Doxil; Liposomal doxorubicin; Ovarian cancer
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
NAVELBINE;
TREOSULFAN;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
BUSULFAN;
DIAGNOSTIC AGENT;
DRUG CARRIER;
DRUG DERIVATIVE;
LIPOSOME;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
CANCER INHIBITION;
CHEMOSENSITIVITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG TUMOR LEVEL;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
OVARY CANCER;
PRIORITY JOURNAL;
RECURRENT CANCER;
DRUG DESIGN;
DRUG SCREENING;
MIDDLE AGED;
OVARY TUMOR;
TUMOR RECURRENCE;
ADENOSINE TRIPHOSPHATE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBIOTICS, ANTHRACYCLINE;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BUSULFAN;
CISPLATIN;
DOXORUBICIN;
DRUG CARRIERS;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
HUMAN;
LIPOSOMES;
MIDDLE AGE;
NEOPLASM RECURRENCE, LOCAL;
OVARIAN NEOPLASMS;
SUPPORT, NON-U.S. GOV'T;
VINBLASTINE;
ANTIBIOTICS, ANTINEOPLASTIC;
HUMANS;
MIDDLE AGED;
|
|
EID: 0036021025
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: 10.1097/00001813-200207000-00009 Document Type: Article |
|
Times cited : (10)
|
|
References (29)
|
